Matthew Davidson
Overview
Explore the profile of Matthew Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antony Jose S, Cowan N, Davidson M, Godina G, Smith I, Xin J, et al.
Nanomaterials (Basel)
. 2025 Mar;
15(5).
PMID: 40072159
Cellulose nanofibers (CNFs), cellulose nanomaterials (CNMs), and cellulose-based composites represent a convergence of material science, sustainability, and advanced engineering, paving the way for innovative and eco-friendly materials. This paper presents...
2.
Hutchings G, Catlow C, Davidson M, Rosseinsky M, Williams C
Philos Trans A Math Phys Eng Sci
. 2024 Sep;
382(2282):20230274.
PMID: 39307159
No abstract available.
3.
Nolan K, Weiland A, Lepper B, Aultman J, Murphy L, Ruby B, et al.
Sci Rep
. 2023 Aug;
13(1):12910.
PMID: 37558779
No abstract available.
4.
Murad M, Low L, Davidson M, Murray P, Rauz S, Wallace G
J Inflamm (Lond)
. 2022 Apr;
19(1):5.
PMID: 35361212
Background: Behçet's disease (BD) is a multisystem autoinflammatory disease characterised by mucosal ulceration, ocular, neural, joint and skin inflammation. The cause of BD is not known but there is a...
5.
Deshmukh M, Liu Y, Rim T, Venkatraman A, Davidson M, Yu M, et al.
Comput Biol Med
. 2021 Aug;
137:104675.
PMID: 34425417
Background: Granular dystrophy is the most common stromal dystrophy. To perform automated segmentation of corneal stromal deposits, we trained and tested a deep learning (DL) algorithm from patients with corneal...
6.
Anand M, Baletto F, Bugaev A, Catlow R, Claeys M, Conway M, et al.
Faraday Discuss
. 2021 May;
229:131-160.
PMID: 34008631
No abstract available.
7.
Eichenfield L, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, et al.
Am J Clin Dermatol
. 2021 Feb;
22(2):257-265.
PMID: 33599960
Background: Compounded cantharidin has been used for decades to treat molluscum contagiosum but lacks rigorous clinical evidence to support its safety and efficacy. VP-102 is a shelf-stable drug-device combination product...
8.
Niazi S, Brabec B, Anschutz L, Willson C, Davidson M, Burnett P
J Drugs Dermatol
. 2021 Jan;
20(1):70-75.
PMID: 33400412
Background: This Phase 2, open-label study evaluated the safety, efficacy, systemic exposure, and impact on quality of life (QoL) with treatment using VP-102, a drug-device combination containing cantharidin (0.7% w/v)...
9.
Haldar D, Janmohamed A, Plant T, Davidson M, Norman H, Russell E, et al.
Liver Int
. 2020 Oct;
41(3):535-544.
PMID: 33022821
Background And Aims: A variety of auto-antibody assays are available as part of the clinical care of patients with liver disease. We sought to better understand the clinical utility of...
10.
Eichenfield L, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, et al.
JAMA Dermatol
. 2020 Sep;
156(12):1315-1323.
PMID: 32965495
Importance: Molluscum contagiosum (MC) is a common viral skin infection that primarily affects children. Cantharidin, a topical vesicant, has a long history of use for MC in compounded formulations, but...